JYLMARIE SOTOMAYOR CRUZ: Open Payments
NPI 1861083081 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,908 in 132 payments from 22 companies in 2025. Trend: 2023 $1,346 · 2024 $1,565 · 2025 $2,908
Food & beverage: $2,874Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $623 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $455 |
| GlaxoSmithKline, LLC. | 22 | $378 |
| Regeneron Healthcare Solutions, Inc. | 10 | $199 |
| Verona Pharma, Inc. | 10 | $175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $168 |
| Insmed, Inc. | 5 | $133 |
| JAZZ PHARMACEUTICALS INC. | 4 | $113 |
| Grifols USA, LLC | 4 | $105 |
| GENZYME CORPORATION | 3 | $81 |
Products named: GLASSIA, FASENRA, DUPIXENT, NUCALA, Ohtuvayre, TRELEGY ELLIPTA, BREZTRI, Arikayce.
Industry payments across FL — which companies pay providers there.
